FDA Approved: DRONABINOL — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved Rhodes Pharmaceuticals L.P.'s supplemental application for dronabinol, authorizing an update to the approved product under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea and Vomiting Due to Cancer Chemotherapy
• Weight Loss Associated with HIV Infection Aids

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)